BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/NLK/Compounds

Compounds That Target NLK

nemo like kinase · 15 compounds in BiohacksAI corpus

NLK (nemo like kinase) is a biological target with 15 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into NLK modulation for therapeutic and biohacking applications.

View NLK target page →UniProt: Q9UBE8 ↗
Most Studied Compounds for NLK
1
Sorafenib
300+
studies
2
Dasatinib
299+
studies
All 15 Compounds — Ranked by Evidence
1
Gefitinib
5.67
confidence
2
Sb 203580
4.92
confidence
3
Foretinib
4.34
confidence
4
Bosutinib
4.08
confidence
5
Doramapimod
4.06
confidence
6
Pazopanib
3.69
confidence
7
Sb 202190
3.64
confidence
8
Lestaurtinib
3.04
confidence
9
Gsk 690693
2.64
confidence
10
Ast 487
2.56
confidence
11
Tak 285
2.40
confidence
12
Encorafenib
2.20
confidence
13
Osi 027
2.08
confidence
14
Sorafenib
300+
studies
1.61
confidence
15
Dasatinib
299+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for NLK (nemo like kinase). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: NLK target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.